Objective—Registry to report our single-centre experience in closing defects of the atrial
septum. Methods—Between 1996 and 2001, transcatheter device closure of significant atrial …

Background: The STARFlex (SF) device is a CardioSEAL (CS) double‐umbrella device that
has been modified by the addition of a self‐centering mechanism comprised of nitinol …

During a 21-month period ending in August 1991, 12 patients underwent transcatheter
closure of atrial septal defect (ASD) with a “buttoned” device through an 8Fr sheath, using an …

Various devices for transcatheter ASD closure are undergoing clinical trials. Each new
device claims advantages in terms of safety and efficacy over earlier devices. We report …

A feasibility clinical study was conducted for the transcatheter occlusion of large ostium
secundum atrial septal defects with the centering buttoned device. The centering buttoned …

Recent experience with the spring-loaded patent ductus arteriosus (PDA) occluder has
demonstrated several advantages of this device in the closure of intracardiac defects …

OBJECTIVE To review the outcomes of transcatheter closure of atrial septal defects using
the Cardio-Seal implant. DESIGN A prospective interventional study. SETTING Tertiary …

Since the introduction of transcatheter interventional occlusion of atrial septal defects (ASDs)
by King and coworkers, the device closure has become the standard treatment of selected …

The Amplatzer septal occluder (AGA Medical Corporation, Golden Valley, MN) is designed
to be an ideal device for the transcatheter closure of ostium secundum atrial septal defects …

We present three cases of multiple interatrial communications to illustrate the extended use
of the Amplatzer septal occluder and to highlight procedural techniques. The first case …